MLKL and neoplasm: This inhibition also reduces liver metastasis in NOD-SCID mice injected with MLKL-overexpressing tumour cells conditioned with METs-containing CM (Fig. 6l), confirming that MLKL-driven necroptosis induces MET formation, enhancing tumour cell metastasis.